Founded in 2017, Capital Rx is a rapidly growing health technology company that specializes in pharmacy benefit management (PBM). The company aims to transform prescription pricing and patient care through its innovative Clearinghouse Model, which enhances the pharmacy supply chain and reduces costs for employer groups. Capital Rx offers a comprehensive suite of services, including full-service PBM solutions and a cloud-native platform called JUDI®, which streamlines operations and supports a wide range of clients, from large self-funded employers to public sector entities. With a strong focus on transparency and client satisfaction, Capital Rx has achieved impressive metrics, including a 99.5% client retention rate and a Net Promoter Score exceeding 90, positioning itself as a leader in the PBM market.
CybSafe is cyber security software that educates, nudges, and provides real-time, tailored cyber assistance to users via a mobile and web app. The platform for behavioral security and data analytics assists people in making better security decisions and improving their security behavior. It also provides metrics for security behavior, culture, and risk reporting, allowing organizations to anticipate security issues. CybSafe is built on a data-driven model of human behavior and makes use of SebDB, the world's most comprehensive security behavior database.
Cyware provides cyber fusion solutions to help businesses detect and stop advanced cyberattacks. Cyware offers the technology organizations need to build a virtual cyber fusion center. With separate but integrated solutions including an advanced threat intel platform (TIP), vendor-agnostic security automation (SOAR), and security case management, organizations can increase speed and accuracy while reducing costs and analyst burnout. Cyware's virtual cyber fusion solutions make secure collaboration, information sharing, and enhanced threat visibility a reality for enterprises, sharing communities (ISAC/ISAO), MSSPs, and government agencies of all sizes and needs.
ETCH commercializes a chemical process that generates low-cost hydrogen by splitting natural gas into hydrogen and solid carbon. The process can be powered by either natural gas, hydrogen, or electricity. Carbon generated by the process is pure and can be stored in environmentally benign facilities.
Proscia develops a digital pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes. Its platform utilizes computing technologies that unlock hidden data not visible to the human eye and turns that data into valuable insights to help physicians accelerate the development of life-saving advances.